This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Advances in Neurodegenerative Disease Research and Therapy
joint with New Frontiers in Neuroinflammation: What Happens When CNS and Periphery Meet?
Organizer(s): Li Gan, Leonard Petrucelli and Morgan H. Sheng
Date: June 17 - 21, 2018
Location: Keystone Resort, Keystone, CO, USA
Sponsored by Ionis Pharmaceuticals, Inc., Merck & Co., Inc., Nestlé Institute of Health Sciences, Roche and Takeda Pharmaceutical Company Limited
Summary of Meeting:
As the world population ages, neurodegenerative diseases are becoming the new epidemic in both developed and developing countries. Progress made in human genetics has revealed increasingly more disease-associated genes for Alzheimer’s disease (AD), Parkinson’s disease (PD), Frontotemoral dementia (FTD), amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders. These discoveries have linked neurodegenerative diseases with several common key biological processes that have so far been under-studied, including RNA metabolism, protein trafficking and innate immune responses. By focusing on these emerging areas in neurodegenerative disease research, this conference seeks to challenge the current research paradigms and to inspire in-depth discussion and exploration. The program assembles leaders from various fields to facilitate interactions between groups using diverse approaches, by providing a platform to cross-fertilize ideas and to encourage new collaborations that could lead to novel mechanisms and therapeutic targets against neurodegenerative diseases.
Scholarship Deadline: February 15 2018
Discounted Abstract Deadline: February 15 2018
Abstract Deadline: March 15 2018
Discounted Registration Deadline: April 18 2018
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Ionis Pharmaceuticals, Inc.Merck & Co., Inc.Nestlé Institute of Health SciencesRocheTakeda Pharmaceutical Company Limited
We gratefully acknowledge additional support from these exhibitors at this conference:
AlzheimerDementia Consortium
We gratefully acknowledge additional support for this conference from:
Charles RiverTocris Bioscience
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Ionis Pharmaceuticals, Inc.

Sanofi US
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Neurological Disorders and Stroke (NINDS)
Grant No. 1R13NS106977-01
Funding for this conference was made possible (in part) by 1R13NS106977-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found